The Road to Approval of a COVID-19 Vaccine by the Food and Drug Administration

Upon completion of this activity, learners will be able to:

1. Explain the guidance from the FDA to industry on development and licensure of vaccines to prevent COVID-19 regarding clinical trials.
2. Describe the characteristics of 2 COVID-19 vaccines that submitted a request for an emergency use authorization.